当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:620.72亿  总市值:782.44亿
流通股本:21.18亿   总股本:26.70亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润30.56亿元,每股收益0.95元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益6081159.99万元,未分配利润2823379.93万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产11812073.85万元,负债5730913.86万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入29,393,385,360.9119,514,431,849.599,420,322,797.3441,067,195,862.59
营业总成本28,415,595,587.618,904,362,502.049,130,342,151.6839,397,511,520.64
其他经营收益
营业利润3,906,765,379.572,761,208,390.861,358,771,228.344,245,103,909.31
利润总额3,837,343,481.792,718,481,583.081,347,541,972.014,169,281,679.72
净利润3,056,091,951.682,100,210,564.8941,566,276.853,512,440,385
每股收益
其他综合收益-385,229,723.22-32,659,264.99-110,471,546.9543,142,250.33
综合收益总额2,670,862,228.462,067,551,299.81831,094,729.93,555,582,635.33
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计32,145,481,005.8834,342,267,603.1934,438,609,708.9334,491,060,582.73
非流动资产:
非流动资产合计85,975,257,507.1384,485,669,451.9183,551,879,181.1682,969,506,766.54
资产总计118,120,738,513.01118,827,937,055.1117,990,488,890.09117,460,567,349.27
流动负债:
流动负债合计35,086,945,012.2236,023,336,557.9735,500,536,915.2537,452,669,252.79
非流动负债:
非流动负债合计22,222,193,608.3222,489,492,119.0321,640,050,046.7620,074,169,184.16
负债合计57,309,138,620.5458,512,828,67757,140,586,962.0157,526,838,436.95
所有者权益(或股东权益):
归属于母公司股东权益合计48,028,502,901.0547,397,623,662.6747,923,631,569.9547,261,106,860.73
股东权益合计60,811,599,892.4760,315,108,378.160,849,901,928.0859,933,728,912.32
负债和股东权益合计118,120,738,513.01118,827,937,055.1117,990,488,890.09117,460,567,349.27
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计32,212,081,100.7421,388,993,511.9610,431,224,855.4743,172,147,821.77
经营活动现金流出小计28,830,312,535.0319,254,993,017.659,375,544,977.0238,695,166,559.55
经营活动产生的现金流量净额3,381,768,565.712,134,000,494.311,055,679,878.454,476,981,262.22
投资活动产生的现金流量:
投资活动现金流入小计2,888,011,838.782,012,663,450.931,275,324,161.382,405,322,190.85
投资活动现金流出小计4,399,844,279.572,872,400,465.891,460,415,546.786,018,645,562.07
投资活动产生的现金流量净额-1,511,832,440.79-859,737,014.96-185,091,385.4-3,613,323,371.22
筹资活动产生的现金流量:
筹资活动现金流入小计26,869,314,775.6616,848,567,870.256,711,769,738.5833,369,274,946.3
筹资活动现金流出小计30,113,741,396.8518,308,768,144.077,345,397,027.4234,371,861,283.66
筹资活动产生的现金流量净额-3,244,426,621.19-1,460,200,273.82-633,627,288.84-1,002,586,337.36
汇率变动对现金及现金等价物的影响-80,826,833.379,762,529.48,912,313.0327,989,327.43
现金及现金等价物净增加额-1,455,317,329.64-176,174,265.07245,873,517.24-110,939,118.93
期末现金及现金等价物余额7,936,132,457.479,215,275,522.049,637,323,304.359,391,449,787.11
补充资料:
现金及现金等价物的净增加额--176,174,265.07--110,939,118.93
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中国银河程培,宋丽莹1.241.441.752025-10-28
天风证券杨松1.271.501.792025-09-14
中信证券陈竹1.251.481.792025-09-01
中金公司俞波,张琎1.301.56--2025-08-28
中国银河程培,宋丽莹1.241.451.752025-08-26
TOP↑